Table 1.
Parameters, % (n) | Overall | Non-Thyroid Nodule | Thyroid Nodules | p | OR | 95%CI | p value |
---|---|---|---|---|---|---|---|
(N = 56729) | (N = 46099) | (N = 10630) | |||||
MetS | 28.7 (16308) | 26.6 (12251) | 38.2 (4057) | 0.000 | 1.069 | 1.011-1.129 | 0.018 |
Male | 32.9 (9733) | 31.2 (7769) | 42.3 (1964) | 0.000 | 1.132 | 1.047-1.224 | 0.002 |
Female | 24.2 (6575) | 21.2 (4482) | 35.0 (2093) | 0.000 | 0.999 | 0.923-1.081 | 0.985 |
Central obesity | 34.4 (19526) | 32.2 (14864) | 43.9 (4662) | 0.000 | 1.108 | 1.044-1.175 | 0.001 |
Male | 39.0 (11518) | 37.3 (9303) | 47.7 (2215) | 0.000 | 1.120 | 1.027-1.220 | 0.010 |
Female | 29.5 (8008) | 26.3 (5561) | 40.9 (2447) | 0.000 | 1.081 | 0.996-1.174 | 0.063 |
Hypertriglyceridemia | 28.2 (15977) | 27.6 (12741) | 30.4 (3236) | 0.000 | 0.969 | 0.920-1.020 | 0.229 |
Male | 34.8 (10285) | 34.5 (8600) | 36.3 (1685) | 0.018 | 0.980 | 0.912-1.053 | 0.575 |
Female | 21.0 (5692) | 19.6 (4141) | 25.9 (1551) | 0.000 | 0.950 | 0.882-1.023 | 0.175 |
Low HDL-C | 20.3 (11492) | 20.1 (9255) | 21.0 (2237) | 0.025 | 0.899 | 0.849-0.951 | 0.000 |
Male | 14.7 (4333) | 14.7 (3657) | 14.6 (676) | 0.848 | 0.954 | 0.868-1.048 | 0.326 |
Female | 26.4 (7159) | 26.4 (5598) | 26.1 (1561) | 0.564 | 0.869 | 0.810-0.933 | 0.000 |
Abnormal BP | 43.8 (24835) | 41.3 (19051) | 54.4 (5784) | 0.000 | 1.129 | 1.073-1.188 | 0.000 |
Male | 52.2 (15444) | 50.4 (12564) | 62.0 (2880) | 0.000 | 1.080 | 1.004-1.161 | 0.038 |
Female | 34.6 (9391) | 30.6 (6487) | 48.5 (2904) | 0.000 | 1.170 | 1.090-1.256 | 0.000 |
Hyperglycemia | 45.8 (26008) | 43.3 (19978) | 56.7 (6030) | 0.000 | 1.070 | 1.019-1.123 | 0.007 |
Male | 48.5 (14348) | 46.5 (11593) | 59.3 (2755) | 0.000 | 1.079 | 1.005-1.159 | 0.036 |
Female | 42.9 (11660) | 39.6 (8385) | 54.7 (3275) | 0.000 | 1.063 | 0.994-1.137 | 0.075 |
TIDE, Thyroid disorders, Iodine status and Diabetes Epidemiological; MetS, metabolic syndrome; HDL-C, high density lipoprotein cholesterol; BP, blood pressure.